当前位置：药药网 / 医药文献 /临床试验药物安全性(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于0,小于852)：
临床试验药物安全性 1506条(本栏目收费,不能显示细节,电话13136136841)
degree of certainty,229
229
primary objective of the study,228
228
treatment effect expected,229
229
statistical methods for determining trial size,231
231
statistical terms commonly used in sample size calculations,230
230
superiority analysis versus non-inferiority analysis,223,226
223 226
time to event variables,239,241
239 241
two-tailed test,212,214
212 214
writing a sample size section of a clinical study protocol,244,245
244 245
Astrocytoma everolimus for,165
165
Atherosclerosis C-reactive protein as biomarker,398,400
398 400
package insert of,698,699
698 699
Add-on design active control,59,60
59 60
Adjuvant therapy chronic drug administration,327
327
metastasis risk reduction,326,327
326 327
meanings of adjuvant,327,328
327 328
Adverse event (AE) abnormal laboratory values,493 494 493 494
adverse drug reaction,494
494
anticipation in clinical study design,487
487
cause-and-effect data from raw data,522,523
522 523
anticipated versus unanticipated,500,502
500 502
drug induction,495,496
495 496
statistician considerations,496
496